FRANKLIN, Tenn., Oct. 23, 2024 (GLOBE NEWSWIRE) — Clover Well being Investments, Corp. (Nasdaq: CLOV) (Clover Well being), right this moment introduced that it’s going to report third quarter 2024 monetary outcomes after market shut on Wednesday, November 6, 2024. Administration will host a convention name and webcast at 5:00 p.m. Japanese Time on November 6, 2024, to debate Clover Well being’s third quarter 2024 enterprise and monetary outcomes.
Third Quarter 2024 Convention Name and Webcast Particulars:
- What: Clover Well being’s Third Quarter 2024 Earnings Convention Name
- When: Wednesday, November 6, 2024, at 5:00 p.m. Japanese Time
- Dial In: To entry the decision through phone please dial 800-579-2543 (for U.S. callers) or 785-424-1789 (for callers outdoors the U.S.) and enter the convention ID: CLOVQ324
- Webcast: A dwell and archived webcast of the convention name might be accessible from the Investor Relations part of Clover Well being’s web site at https://buyers.cloverhealth.com/ for 12 months
About Clover Well being:
Clover Well being (Nasdaq: CLOV) is a doctor enablement expertise firm dedicated to bringing entry to nice healthcare to everybody on Medicare. This features a well being equity-based give attention to seniors who’ve traditionally lacked entry to reasonably priced, high-quality healthcare. Our technique is powered by our software program platform, Clover Assistant, which is designed to mixture affected person information from throughout the healthcare ecosystem to help scientific decision-making and enhance well being outcomes by way of the early identification and administration of persistent illness. For our members, we offer PPO and HMO Medicare Benefit plans in a number of states, with a differentiated give attention to our flagship wide-network, high-choice PPO plans. For healthcare suppliers outdoors Clover Well being’s Medicare Benefit plan, we goal to increase the advantages of our data-driven expertise platform to a wider viewers through our subsidiary, Counterpart Well being, and to allow enhanced affected person outcomes and diminished healthcare prices on a nationwide scale. Clover Well being has revealed information demonstrating the expertise’s affect on Treatment Adherence, in addition to the sooner identification and administration of Diabetes and Continual Kidney Illness.
Press Contact:
Andrew Nonetheless-Baxter
press@cloverhealth.com
Investor Relations Contact:
Ryan Schmidt
buyers@cloverhealth.com
Supply: Clover Well being Investments, Corp.